Abstract
The problem of human immunodeficiency virus (HIV) infection and that of the acquired immunodeficiency syndrome (AIDS) are becoming increasingly important in clinical transplantation. The epidemiologic characteristics of this infection are important factors in determining the impact of this infection on transplant patients: in particular, the presence of a transmissible virus in the blood, tissues, and body fluids of even asymptomatic individuals for prolonged periods; the role of lymphocyte activation in accelerating the pace and effects of HIV infection, with the transplant patient having more reasons for lymphocyte activation than other patient categories; and the possible contributions of immunosuppressive therapy to the course of HIV infection. Already, at least 20 cases of primary HIV infection conveyed by infected blood or allografts at the time of transplant have been noted; a similar number of transplants have been carried out in asymptomatic carriers of the virus. The initial impression is that the course of HIV infection in these patients is accelerated, but information is incomplete and an international registry for the study of this problem has been established.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Allain JP, Laurian Y, Paul DA, Verroust F, Leuther M, Gazengel C, Senn D, Larrieu MJ, Bosser C (1987) Long-term evaluation of HIV antigen and antibodies to p24 and gp41 in patients with hemophilia: potential clinical importance. N Engl J Med 317: 1114–1121
Anonymous (1985) Provisional public health service interagency recommendations for screening donated blood and plasma for antibody to the virus causing acquired immunodeficiency syndrome. MMWR 34: 1–5
Anonymous (1987) Human immunodeficiency virus infection transmitted from an organ donor screened for HIV antibody — North Carolina. MMWR 36: 306–308
Anton J, Smith B, Ewenstein BM, Arceci RJ, Lipton JM, Page PL, Rappaport JM (1986) HTLV-III infection after bone marrow transplantation. Blood 67: 160–163
Bowen DL, Lance HC, Fauci AS (1985) Immunopathogenesis of the acquired immunodeficiency syndrome. Ann Intern Med 103: 704–709
Dalgleish AG, Beverley PCL, Clapham PR, Crawford DH, Greaves MF, Weiss RA (1984) The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312: 763–767
Fassbinder W, Fürsch A, Kühnl P, Schoeppe W (1987) Human immunodeficiency virus antibody screening in patients on renal replacement therapy: prevalence of false-positive results. Nephrol Dial Transplant 2: 248–250
Feduska NJ, Perkins HA, Melzer J, Amend WJC, Vincent F, Tomlanovich S, Garavoy M, Salvatierra O (1987) Observations relating to the incidence of AIDS and other possibly associated conditions in a large population of renal transplant recipients. Transplant Proc 19: 2161–2166
Friedland GH, Klein RS (1987) Transmission of the human immunodeficiency virus. N Engl J Med 317: 1125–1135
Ho DD, Rota TR, Hirsch MS (1986) Infection of monocyte/ macrophages by human T lymphotrophic virus type III. J Clin Invest 77: 1712–1715
Ho DD, Pomerantz RJ, Kaplan JC (1987) Pathogenesis of infection with human immunodeficiency virus. N Engl J Med 317: 278–286
Klatzmann D, Barre-Sinoussi F, Nugeyre MT, Danquet C, Vilmer E, Griscelli C, Brun-Veziert F, Rouzioux C, Gluckman JC, Chermann JC, Montagnier L (1984) Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. Science 225: 59–63
Klatzmann D, Champagne E, Chamaret S, Gruest J, Guetard D, Hercend T, Gluckman JC, Montagnier L (1984) T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312: 767–768
Kumar P, Pearson JE, Martin DH, Leech SH, Buisseret PD, Bezbak HC, Gonzales FM, Royer JR, Streicher HZ, Saxinger WC (1987) Transmission of human immunodeficiency virus by transplantation of a renal allograft, with development of the acquired immunodeficiency syndrome. Ann Intern Med 106: 244–245
L'Age-Stehr J, Schwarz A, Offermann G, Langmaack H, Bennhold I, Niedrig M, Koch MA (1985) HTLV-III infection in kidney transplant recipients. Lancet II: 1361
Margolick JB, Volman DJ, Fallks TM, Fauci AS (1987) Amplification of HTLV-III/LAV infection by antigen-induced activation of T cells and direct suppression by virus of lymphocyte blastogenic response. J Immunol 138: 1719–1723
Margreiter R, Fuchs D, Hansen A, Hengster P, Schonitzer D, Spielberger M, Dierich MP, Wachter H (1986) HIV infection in renal allograft recipients. Lancet II: 398
Mayer KH, Stoddard AM, McCusker J, Ayotte D, Ferriani R, Groopman JE (1986) Human T-lymphotrophic virus type III in high-risk, antibody-negative homosexual men. Ann Intern Med 104: 194–196
McDougal JS, Mawle A, Cort SP, Nicholson JK, Cross GD, Scheppler-Campbell JA, Hicks D, Sligh J (1985) Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen. J Immunol 135: 3151–3162
McDougal JS, Kennedy MS, Sligh JM, Cort SP, Mawle A, Nicholson JK (1986) Binding of HTLV-III/LAV to T4+T cells by a complex of the 110K viral protein and the T4 molecule. Science 231: 382–385
Milgrom M, Esquenazi V, Fuller L, Roth D, Kyriakides GK, Miller J (1985) Acquired immunodeficiency syndrome in a transplant patient. Transplant Proc [Suppl 2] 17: 75–76
Nicholson JKA, Cross GD, Callaway CS, McDougal JS (1986) In vitro infection of human monocytes with human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). J Immunol 137: 323–329
Oliveira DBG, Winearls CG, Cohen J,Ind PW, Williams G (1986) Severe immunosuppression in a renal transplant recipient with HTLV-III antibodies. Transplantation 41: 260–262
Prompt CA, Reis MM, Grillo FM, Kopstein J, Kraemer E, Manfro RC, Maia MH, Comiran JB (1985) Transmission of AIDS virus at renal transplantation. Lancet II: 672
Ranki A, Valle S-L, Krohn M, Antonen J, Allain JP, Leuther M, Franchini G, Krohn K (1987) Long latency precedes overt seroconversion in sexually transmitted human immunodeficiency virus infection. Lancet II: 589–593
Rubin RH, Jenkins RL, Shaw BW Jr, Shaffer D, Pearl RH, Erbs S, Monaco AP, Van Thiel DH (1987) The acquired immunodeficiency syndrome and transplantation. Transplantation 44: 1–4
Salahuddin SZ, Palestine AG, Heck E, Ablashi D, Luckenback M, McCulley JP, Nussenblatt RB (1986) Isolation of the human T-cell leukemia/lymphotrophic virus type III from the cornea. Am J Ophthalmol 101: 149–152
Salahuddin SZ, Rose RM, Groopman JE, Markham PD, Gallo RC (1986) Human T lymphotropic virus type III infection of human alveolar macrophages. Blood 68: 281–284
Shaffer D, Pearl RH, Jenkins RL, Hammer SM, Dzik WJ, Groopman JE, Benotti PN, Monaco AP (1987) HTLV-III/LAV infection in kidney and liver transplantation. Transplant Proc 19: 2176–2180
Ward JW, Deppe DA, Samson S, Perkins H, Holland P, Fernando L, Feorino PM, Thompson P, Kleinman S, Allen J (1987) Risk of human immunodeficiency virus infection from blood donors who later developed the acquired immunodeficiency syndrome. Ann Intern Med 106: 61–62
Zagury D, Bernard J, Leonard R, Cheynier R, Feldman M, Sarin PS, Gallo RC (1986) Long-term cultures of HTLV-III-infected T cells: a model of cytopathology of T-cell depletion in AIDS. Science 231: 850–853
Author information
Authors and Affiliations
Additional information
In cooperation with the Registry for the Study of AIDS in Transplantation
About this article
Cite this article
Rubin, R.H., Tolkoff-Rubin, N.E. The problem of human immunodeficiency virus (HIV) infection and transplantation. Transplant Int 1, 36–42 (1988). https://doi.org/10.1007/BF00337847
Issue Date:
DOI: https://doi.org/10.1007/BF00337847